GlassScriptPhysician profile
Robert H Nichols
NPI 1538384375
$1,754.43
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $953 · 2020: $766 · 2022: $35.66.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $461.71 | 2019-2020 | |
| Amgen INC. | $334.91 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $231.70 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $109.63 | 2019-2020 | |
| Allergan, INC. | $100.99 | 2019-2020 | |
| Pfizer INC. | $96.71 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $55.69 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.50 | 2019-2022 | |
| Boston Scientific Corporation | $51.04 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $43.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $43.01 | 2019-2020 | |
| Abbvie INC. | $32.32 | 2020-2022 | |
| Lilly USA, LLC | $24.18 | 2019 | |
| Daiichi Sankyo INC. | $17.37 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $15.32 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $15.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.89 | 2019 | |
| Esperion Therapeutics, INC. | $14.19 | 2020 | |
| Lundbeck LLC | $14.08 | 2019 | |
| Merck Sharp & Dohme LLC | $14.08 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.61 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Nichols listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.